Tick-Borne Relapsing Fever Caused by Borrelia persica in Traveler to Central Asia, 2019
, 2020 Veronika Muigg +8 more
openalex +2 more sources
The Resolution of Relapsing Fever Borreliosis Requires IgM and Is Concurrent with Expansion of B1b Lymphocytes [PDF]
, 2003 Kishore R. Alugupalli +5 more
openalex +1 more source
Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial
BJU International, Volume 135, Issue 4, Page 638-647, April 2025.Objectives To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX‐A) injections for overactive bladder. Patients and Methods This single‐centre, randomised, double‐blind, placebo‐controlled two period crossover trial was conducted on women scheduled for ...
Meryam El Issaoui +2 more
wiley +1 more source
Imported Tickborne Relapsing Fever, France
Emerging Infectious Diseases, 2005 Benjamin Wyplosz +9 more
doaj +1 more source
Epistaxis and thrombocytopenia as major presentations of louse borne relapsing fever: Hospital-based study. [PDF]
PLoS One, 2022 Abera EG +5 more
europepmc +1 more source
Louseborne relapsing fever in young migrants, sicily, Italy, july-september 2015 [PDF]
, 2016 Ciervo, A. +9 more
core +1 more source
Notes on Organisms Serologically Related to S. Enteritidis Gärtner. II.: Observations on S. Paratyphus N2 (Salmonella, Type Moscow): an Organism Complicating Relapsing Fever [PDF]
, 1930 E. P. Hicks
openalex +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
British Journal of Pharmacology, EarlyView.Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Journal of Arthropod-Borne Diseases, 2007 Tick-borne diseases such as relapsing fever and Crimean-Congo Hemorrhagic Fever (CCHF) are of public health impor¬tance in Iran. There are 471 reported cases of relapsing fever in 2003, according to the Ministry of Health of Iran.The num¬ber of cases has
Z Aghighi +7 more
doaj
Cancer Science, EarlyView.J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu +7 more
wiley +1 more source